Navigation Links
DART Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy
Date:3/20/2013

of SARMs for other neuromuscular diseases such as FSHD (Facioscapulohumeral muscular dystrophy), Spinal Muscular Atrophy, Charcot Marie Tooth and ALS (Amyotrophic lateral sclerosis).

"We know that making DMD a chronic, manageable disease will require a cocktail of therapies," said Dr. Diana Escolar , Chief Medical Officer of DART Therapeutics. "Phase one studies in adult volunteers show that DT-200 is safe and well-tolerated. Through our work with this SARM, we intend to explore the value of increasing muscle mass and potentially strength in diseased muscle, which could lead to development of a therapy that addresses a key unmet need in the future DMD cocktail."

In the second half of 2013, DART will initiate a phase 2a study in adults with normal muscle followed by a study in abnormal muscle wasting to assess the effects of DT-200 in increasing lean body mass, muscle strength and motor function. This study will provide proof of concept that either normal muscle, abnormal muscle or both can respond to SARMs, and that the effect in increasing muscle mass will be clinically beneficial. Further studies in pediatric DMD or other neuromuscular disorders will follow if these studies are positive.

"DART was created in part to explore the unanswered questions in DMD," said Gene Williams , CEO of DART. "Our model gives us a unique opportunity to ask the difficult questions and commit research dollars to areas that may have been neglected due to time and cost constraints normally associated with traditional biotech firms. We are optimistic that SARMs will play a role in the eventual DMD cocktail and may yield benefits for several other rare diseases, which we hope will benefit children beyond the DMD community."

Galapagos completed a phase one study of its SARM drug candidate in healthy volunteers, which showed positive results in terms of exposure and tolerability. Several Proof of Conce
'/>"/>

SOURCE DART Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
3. Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
4. Echo Therapeutics Achieves ISO 13485 Certification
5. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
6. Echo Therapeutics Appoints Robert Doman to Board of Directors
7. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
8. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
9. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
10. PTC Therapeutics Closes $60 Million Private Financing
11. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Scientific Corporation (NYSE: BSX ) will webcast a conference ... to review financial results and business highlights for the first ... first quarter financial results prior to the conference call. ... , president and chief executive officer, and Dan Brennan ... A live webcast of the conference call will be available ...
(Date:4/1/2015)... BURNIE, Md. , April 1, 2015 /PRNewswire/ ... patient recruitment solutions for the clinical research industry, ... help with a dermatology study that was falling ... expert recruitment strategies and customized site support programs, ... screening and enrolling, and also increased the number ...
(Date:4/1/2015)... CREEK, Calif. , April 1, 2015  For ... huge difference.  When this is the case, having the ... No one understands this truth better than software solutions ... laboratory management software QATrax.  Recently, the company announced the ... very enthusiastic response from clients. ...
Breaking Medicine Technology:Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2CSSi Quadruples Screening Activity and Speeds Enrollment for Pediatric Dermatology Study 2TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2
... , RESEARCH TRIANGLE PARK, N.C. , ... ) announced today that the U.S. Food and Drug Administration ... add-on therapy for epilepsy in patients ages 13 years and ... label, as Lamictal XR is approved ...
... , , JOHNSTOWN, Pa. , Jan. 29 ... Company), (Pink Sheets: EPGL), ( www.eparent.com ), the parent company ... announce that Stephen L. DeFelice , MD, has joined the EPGL ... nutraceutical products and is credited for introducing the term "nutraceutical."  , ...
Cached Medicine Technology:FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 2FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 3FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 4FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 5FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 6FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 7EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, to Advisory Board 2EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, to Advisory Board 3
(Date:4/1/2015)... It is the meat that has become an American ... around other foods, infused into cocktails and even made into ... gateway meat for vegetarians and the perfect food. To honor ... Institute (NAMI) has developed a new Ultimate Guide to ... processing plant and companion brochure with bacon ...
(Date:4/1/2015)... Pricing Healthcare has added facilities to its website in ... a third of all US states. The new facilities include ... the first dedicated eye center in the country in Oklahoma City, ... , In addition, the site reached a milestone of 10,000 unique ... continue to grow across the country. , 1. New England ...
(Date:4/1/2015)... With so much wet weather over the past few months, ... indoors. When all this time is spent inside, it is ... from Clean Crawls offers excellent advice to homeowners seeking ... One of the ways to improve the air quality in ... states that, “Toluene, Xylene, and Benzene are all Volatile Organic ...
(Date:4/1/2015)... "Giving credit where credit is due is ... inestimable." - Loretta Young , The American Water Resources ... profession. The Call for Nominations for our 2015 ... colleague, or organization for one of these awards. Nominations ... AWRA Awards and view the nomination criteria and form ...
(Date:4/1/2015)... Decora Preset 30 Minute Countdown Timer, a product ... City.’ The product helps in automatically switching off any electronic ... related electronic device is automatically turned off after the set ... “We are glad that this amazing product is now available ... Switch in just a few clicks. The product has been ...
Breaking Medicine News(10 mins):Health News:New Ultimate Guide to Bacon Video Provides Inside Look at How Bacon is Made 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3Health News:3 Simple Ways to Improve Home Air Quality Listed by Clean Crawls in Latest Article 2Health News:Nominations Sought for National Water Resources Awards and Student Scholarships 2Health News:Nominations Sought for National Water Resources Awards and Student Scholarships 3Health News:Leviton Decora Preset 30 Minute Countdown Timer Available On TheHardwareCity.com 2
... in Spanish study , MONDAY, Oct. 5 (HealthDay News) -- ... is rich in fruits, vegetables, whole grains, fish and nuts, ... , "We are speaking of a relative reduction in risk ... Miguel A. Martinez-Gonzalez, chair of preventive medicine at the University ...
... ... president-elect Elizabeth H. Blackburn, Ph.D., and AACR member Carol W. Greider, Ph.D., for winning, ... of how chromosomes are protected by telomeres and the enzyme telomerase. , ... Philadelphia (Vocus) October 5, 2009 ...
... Inc. (Hologic or the Company) (NASDAQ: HOLX ), ... medical imaging systems and surgical products dedicated to serving ... release its fourth quarter and fiscal 2009 operating results ... conjunction with the release, management will host a conference ...
... 5 Empire BlueCross BlueShield (Empire) proudly announced today that it ... Games (WPFG), which will be held in New York City from ... a series of health and wellness activities around Empire,s 75(th) Anniversary ... to celebrate the men and women around the world who are ...
... and Sunnybrook Health Sciences Centre have discovered a previously unidentified ... important new insights into glaucoma, a leading cause of blindness. ... to lack lymphatics, a circulation responsible for pumping fluid and ... from the eye is linked to glaucoma, a leading cause ...
... Ingestion of ,button, batteries may have serious consequences, researchers ... beware: It,s not unusual for children to ingest the ... a new study warns. , Some kids swallow the ... found after monitoring cases at a pediatric hospital over ...
Cached Medicine News:Health News:Mediterranean Diet May Help Prevent Depression 2Health News:Mediterranean Diet May Help Prevent Depression 3Health News:The American Association for Cancer Research Congratulates President-Elect on Nobel Prize 2Health News:The American Association for Cancer Research Congratulates President-Elect on Nobel Prize 3Health News:The American Association for Cancer Research Congratulates President-Elect on Nobel Prize 4Health News:Hologic to Release Fourth Quarter and Fiscal 2009 Operating Results on Monday, November 9, 2009 2Health News:Empire BlueCross BlueShield to Support 2011 World Police & Fire Games in NYC 2Health News:Toronto researchers discover novel circulation in human eye, new glaucoma treatment target 2Health News:Tiny Batteries Can Cause Big Problems for Young Children 2
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 3.5V halogen source....
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 2.5V halogen source....
Medicine Products: